JAMES R SULAT Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JAMES R SULAT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES R SULAT. JAMES R SULAT is Director in AMAG PHARMACEUTICALS INC. ($AVM) and Director in Diadexus, Inc. ($DDXS) and Director in MAXYGEN INC ($MAXY) and Director in MOMENTA PHARMACEUTICALS INC ($MNTA) and Director in Arch Therapeutics, Inc. ($ARTH) and Director in EXICURE, INC. ($XCUR).
Latest Insider Trading Transactions of JAMES R SULAT
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVM, ARTH, DDXS, XCUR, MAXY, MNTA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 04 2021 | XCUR | EXICURE, INC. | SULAT JAMES R | Director | Option Exercise | A | 1.71 | 50,000 | 85,500 | 50,000 | |
Jan 05 2021 | XCUR | EXICURE, INC. | SULAT JAMES R | Director | Option Exercise | A | 1.82 | 43,386 | 78,963 | 43,386 | |
Jan 05 2021 | XCUR | EXICURE, INC. | SULAT JAMES R | Director | Option Exercise | A | 1.82 | 43,386 | 78,963 | 43,386 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 21,289 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 17,326 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 7,543 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 10,110 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 12,787 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 3,575 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 3,800 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 317 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 6,000 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Sell | D | 0.00 | 35,090 | 0 | 0 | 35.1 K to 0 (-100.00 %) |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 21,289 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 17,326 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 7,543 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 10,110 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 12,787 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 3,575 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 3,800 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 317 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 6,000 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Sell | D | 0.00 | 35,090 | 0 | 0 | 35.1 K to 0 (-100.00 %) |
Jun 23 2020 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | P | 0.25 | 340,910 | 85,228 | 340,910 | |
Jun 23 2020 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | O | 0.18 | 454,546 | 81,818 | 0 | |
Jun 23 2020 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Buy | O | 81,818.30 | 454,546 | 37,190,171,901 | 1,376,813 | 922.3 K to 1.4 M (+49.29 %) |
Jun 04 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | A | 8.52 | 21,289 | 181,382 | 21,289 | |
Jun 04 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Grant | A | 0.00 | 10,269 | 0 | 35,090 | 24.8 K to 35.1 K (+41.37 %) |
Dec 23 2019 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | A | 0.23 | 300,000 | 68,760 | 300,000 | |
Jun 21 2019 | MNTA | MOMENTA PHARMACEUT ... | SULAT JAMES R | Director | Option Exercise | M | 0.00 | 4,356 | 0 | 0 | |
Jun 21 2019 | MNTA | MOMENTA PHARMACEUT ... | SULAT JAMES R | Director | Option Exercise | A | 12.64 | 25,000 | 316,000 | 25,000 | |
Jun 21 2019 | MNTA | MOMENTA PHARMACEUT ... | SULAT JAMES R | Director | Buy | M | 0.00 | 4,356 | 0 | 54,090 | 49.7 K to 54.1 K (+8.76 %) |
May 29 2019 | MNTA | MOMENTA PHARMACEUT ... | SULAT JAMES R | Director | Option Exercise | M | 8.85 | 10,000 | 88,500 | 0 | |
May 29 2019 | MNTA | MOMENTA PHARMACEUT ... | SULAT JAMES R | Director | Buy | M | 8.85 | 10,000 | 88,500 | 49,734 | 39.7 K to 49.7 K (+25.17 %) |
May 20 2019 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | A | 10.78 | 17,326 | 186,774 | 17,326 | |
May 20 2019 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Grant | A | 0.00 | 8,116 | 0 | 24,821 | 16.7 K to 24.8 K (+48.58 %) |
Sep 10 2018 | MNTA | MOMENTA PHARMACEUT ... | SULAT JAMES R | Director | Option Exercise | M | 14.79 | 13,500 | 199,665 | 13,500 | |
Sep 10 2018 | MNTA | MOMENTA PHARMACEUT ... | SULAT JAMES R | Director | Buy | M | 14.79 | 13,500 | 199,665 | 39,734 | 26.2 K to 39.7 K (+51.46 %) |
Jul 20 2018 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | A | 0.43 | 110,000 | 46,750 | 110,000 | |
Jul 20 2018 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Grant | A | 0.00 | 110,000 | 0 | 370,000 | 260 K to 370 K (+42.31 %) |
Jul 18 2018 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | M | 0.37 | 30,000 | 11,100 | 0 | |
Jul 18 2018 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Buy | M | 0.37 | 30,000 | 11,100 | 260,000 | 230 K to 260 K (+13.04 %) |
Jun 22 2018 | MNTA | MOMENTA PHARMACEUT ... | SULAT JAMES R | Director | Option Exercise | M | 0.00 | 5,734 | 0 | 0 | |
Jun 22 2018 | MNTA | MOMENTA PHARMACEUT ... | SULAT JAMES R | Director | Option Exercise | A | 0.00 | 4,356 | 0 | 4,356 | |
Jun 22 2018 | MNTA | MOMENTA PHARMACEUT ... | SULAT JAMES R | Director | Option Exercise | A | 22.30 | 8,855 | 197,467 | 8,855 | |
Jun 22 2018 | MNTA | MOMENTA PHARMACEUT ... | SULAT JAMES R | Director | Buy | M | 0.00 | 5,734 | 0 | 26,234 | 20.5 K to 26.2 K (+27.97 %) |
Jun 08 2018 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | A | 24.45 | 7,543 | 184,426 | 7,543 | |
Jun 08 2018 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Grant | A | 0.00 | 3,578 | 0 | 16,705 | 13.1 K to 16.7 K (+27.26 %) |
Jun 22 2017 | MNTA | MOMENTA PHARMACEUT ... | SULAT JAMES R | Director | Option Exercise | A | 0.00 | 5,734 | 0 | 5,734 | |
Jun 22 2017 | MNTA | MOMENTA PHARMACEUT ... | SULAT JAMES R | Director | Option Exercise | A | 17.20 | 11,207 | 192,760 | 11,207 | |
May 22 2017 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | A | 19.25 | 10,110 | 194,618 | 10,110 | |
May 22 2017 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Grant | A | 0.00 | 4,545 | 0 | 13,127 | 8.6 K to 13.1 K (+52.96 %) |
Feb 06 2017 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | A | 0.65 | 200,000 | 130,000 | 200,000 | |
Feb 06 2017 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Grant | A | 0.00 | 200,000 | 0 | 230,000 | 30 K to 230 K (+666.67 %) |
Jun 27 2016 | MNTA | MOMENTA PHARMACEUT ... | SULAT JAMES R | Director | Option Exercise | A | 10.97 | 11,000 | 120,670 | 11,000 | |
Jun 27 2016 | MNTA | MOMENTA PHARMACEUT ... | SULAT JAMES R | Director | Option Exercise | A | 10.97 | 11,000 | 120,670 | 11,000 | |
Jun 27 2016 | MNTA | MOMENTA PHARMACEUT ... | SULAT JAMES R | Director | Grant | A | 0.00 | 5,500 | 0 | 20,500 | 15 K to 20.5 K (+36.67 %) |
Jun 27 2016 | MNTA | MOMENTA PHARMACEUT ... | SULAT JAMES R | Director | Grant | A | 0.00 | 5,500 | 0 | 20,500 | 15 K to 20.5 K (+36.67 %) |
May 31 2016 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | P | 0.44 | 83,333 | 36,500 | 83,333 | |
May 31 2016 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Buy | P | 0.00 | 111,111 | 0 | 868,934 | 757.8 K to 868.9 K (+14.66 %) |
May 23 2016 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | A | 18.35 | 12,787 | 234,641 | 12,787 | |
May 23 2016 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Grant | A | 0.00 | 4,768 | 0 | 8,582 | 3.8 K to 8.6 K (+125.01 %) |
May 05 2016 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | A | 0.39 | 130,000 | 50,700 | 130,000 | |
May 05 2016 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Grant | A | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
Aug 20 2015 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | A | 0.27 | 200,000 | 54,000 | 200,000 | |
Jul 16 2015 | DDXS | Diadexus, Inc. | SULAT JAMES R | Director | Option Exercise | A | 4.21 | 4,000 | 16,840 | 4,000 | |
Jun 11 2015 | MNTA | MOMENTA PHARMACEUT ... | SULAT JAMES R | Director | Option Exercise | A | 22.18 | 17,750 | 393,695 | 133,750 | |
May 26 2015 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | A | 66.18 | 3,575 | 236,594 | 3,575 | |
May 26 2015 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Grant | A | 0.00 | 1,322 | 0 | 3,814 | 2.5 K to 3.8 K (+53.05 %) |
Mar 27 2015 | DDXS | Diadexus, Inc. | SULAT JAMES R | Director | Option Exercise | A | 0.44 | 30,000 | 13,200 | 30,000 | |
Sep 24 2009 | MAXY | MAXYGEN INC | SULAT JAMES R | Director | Option Exercise | A | 0.00 | 353,259 | 0 | 353,259 | |
Sep 24 2009 | MAXY | MAXYGEN INC | SULAT JAMES R | Director | Option Exercise | A | 6.53 | 400,000 | 2,612,000 | 400,000 | |
Sep 24 2009 | MAXY | MAXYGEN INC | SULAT JAMES R | Director | Grant | A | 0.00 | 400,000 | 0 | 400,000 | 0 to 400 K |
Jun 02 2008 | MAXY | MAXYGEN INC | SULAT JAMES R | Director | Option Exercise | A | 5.89 | 17,500 | 103,075 | 17,500 | |
Jun 01 2007 | MAXY | MAXYGEN INC | SULAT JAMES R | Director | Option Exercise | A | 9.81 | 5,000 | 49,050 | 5,000 | |
May 31 2006 | MAXY | MAXYGEN INC | SULAT JAMES R | Director | Option Exercise | A | 7.27 | 5,000 | 36,350 | 5,000 | |
Nov 30 2005 | MAXY | MAXYGEN INC | SULAT JAMES R | Director | Option Exercise | A | 7.08 | 30,000 | 212,400 | 30,000 | |
Jul 06 2005 | MAXY | MAXYGEN INC | SULAT JAMES R | Director | Option Exercise | A | 7.21 | 5,000 | 36,050 | 5,000 | |
Jun 23 2004 | MAXY | MAXYGEN INC | SULAT JAMES R | Director | Option Exercise | A | 9.78 | 5,000 | 48,900 | 5,000 | |
Oct 07 2003 | MAXY | MAXYGEN INC | SULAT JAMES R | Director | Option Exercise | A | 10.69 | 20,000 | 213,800 | 20,000 |
Page: 1